Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT02813902
Eligibility Criteria:
Inclusion Criteria:
* Must be male or female and at least 18 years of age.
* Female patients must be of:
* Non-childbearing potential;
* Childbearing potential, provided negative urine pregnancy test and using effective contraception.
* Dermatologist-rendered diagnosis of AK in the past 2 years.
Exclusion Criteria:
* History of \>2 skin cancers in the past 5 years
* History of dementia
* Cardiovascular disease, defined as Blood Pressure (BP) \<90/60 or Heart rate (HR) \>110 in the past year or a history of myocardial infection
* Inflammatory bowel disease/irritable bowel syndrome
* Treatment with Fluorouracil, imiquimod, diclofenac, or photodynamic therapy in the past 8 weeks
* Intention to seek more aggressive AK therapy such as photodynamic therapy, laser surgery in next 12 months
* Serious psychological illness
* History of alcohol or drug abuse
* Any disease or condition which would interfere with study participation or unduly increase risk.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02813902
Study Brief:
Protocol Section:
NCT02813902